|Lowering prescription drug prices is a major priority for the American people. So why is Speaker Pelosi putting a partisan drug plan, which she knows won’t become law, on theHouse Floor tomorrow? Her bill is unconstitutional. It’s dead on arrival in the Senate. President Trump has vowed to veto it.
But there’s a better way. After months of work, Republican committee leaders recently introduced H.R. 19, The Lower Costs, More Cures Act. Every single provision in H.R. 19 has demonstrated bipartisan support.
H.R. 19 could become law. It could be on the President’s desk tomorrow. Senior citizens could be paying less for prescription drug prices this very month, if only Speaker Pelosi would abandon her extreme partisan plans.
H.R. 3, Pelosi’s partisan drug plan:
- Undermines access to lifesaving medicines. Under Pelosi’s partisan plan, the Congressional Budget Office (CBO) estimates 15 fewer cures would be developed. The Council of Economic Advisers (CEA) estimates it’d be more like 100 fewer cures.
- Uses the weight of the federal government to threaten manufacturers with a 95 percent tax on revenue if they don’t comply with bureaucratic demands. That’s not negotiation, that’s coercion.
- Jeopardizes months of bipartisan work to cap senior citizens’ out-of-pocket costs for prescription drug spending by opting for a partisan plan to appease progressives.
- Is unconstitutional! Analysis by the Congressional Research Service (CRS) concluded Pelosi’s partisan plan could violate both the Fifth Amendment’s Takings Clause, as well as the Eight Amendment’s Excessive Fines Clause.
- Will not be signed by President Trump.
H.R. 19, a bipartisan alternative:
- Encourages innovation of groundbreaking new cures, promotes more low-cost options for patients, and curbs the gaming of the system by drug companies.
- For the first time ever, places a cap on seniors’ out-of-pocket drug costs and allow seniors to manage their annual out-of-pocket spending.
- Makes insulin more affordable.
- Increases transparency and removes uncertainty at the pharmacy counter.
- Cuts the cost of drug administration, including cancer treatment, for Medicare beneficiaries by as much as half.
- Stops subsidizing other developed counties health care through stronger trade agreement with real enforcement mechanisms.
- Could actually become law!